siRNA Transfection Synthetic SMARTPOOL siRNA for PPARg, C/EBPb, and C/EBPa were purchased from Dharmacon. To generate diced siRNA, genespecific primers were designed with an in-house primer program and were used to generate $600 bp cDNA fragments immediately upstream of the stop codon of each mRNA by PCR. An additional set of nested primers was designed to add T7 promoters at both ends of the final cDNA fragment. Nested PCR products were subjected to in vitro transcription, in vitro dicing, and purification to produce siRNA as described previously (Galvez et al., 2007). The OP9 cells were transfected with siRNA by a reverse transfection protocol. For each 96-well well, 2 pmol of diced-pool siRNA was diluted in 10ul of Opti-Mem I Medium. 0.2ul of RNAiMax (Invitrogen) diluted in 10ul of Opti-Mem I was then added, mixed well, and then incubated for 20 min at room temperature. This mixture was then placed into a 96-well, and OP9 cells were added (15,000 cells suspended in 80 ml of growth medium without antibiotics). After 24 hr, the media was replaced with differentiation media to induce differentiation following differentiation method. Specificity for all siRNA used in the paper -PPARg, C/EBPb, C/EBPa, glucocorticoid receptor, and insulin receptor -was verified by demonstrating that the same results were obtained using two different diced pools of siRNA each targeting a different coding region of the respective gene ( Figures S2B and S2C) . Specificity of PPARg, C/EBPb, C/EBPa siRNA was also confirmed using commercially-obtained synthetic siRNA.
Retroviral Infection of Cells
HEK293T were transfected in 6-well wells at 30% confluence using Fugene6 and 1 mg of PCL-ECO packaging construct together with either 1 mg of pBMNi-PPARg-IRES-hcRed, pBMNi-C/EBPa-IRES-GFP, or pBMNi-IRES-GFP expression plasmids. 4 ml of viral supernatant was collected both at 48 and 72 hr after transfection. The 8 ml total of viral supernatant was combined, concentrated using PEG-it virus precipitation solution (System Biosciences), and resuspended in 100ul of PBS to make concentrated retrovirus. 5000 OP9 cells in 100ul of OP9 growth media were plated into each 96-well well 12 hr before infection. 5 ul of concentrated retrovirus plus polybrene (8mg/ml final concentration) was added per 96-well well. After 12 hr, the media in each well was changed to fresh OP9 growth media. Cells were fixed 10 days after infection.
Immunofluorescence Staining OP9 cells were fixed with 3% paraformaldehyde in PBS for 30 min. Then the cells were gently washed 3X with PBS and permeabilized with 0.05% saponin (Sigma #47036), blocked with 3% bovine serum albumin (Sigma #7906) and stained with anti-PPARg (1:500 Santa Cruz Biotech #sc-7273), anti-C/EBPa (1:500, Santa Cruz Biotech #sc-61), anti-C/EBPb (1:500, Santa Cruz Biotech #sc-150), anti-C/EBPb (1:500, Santa Cruz Biotech #sc-7962), anti-pAKT(S473)(1:1000, Cell Signaling #4060) and BODIPY 493/ 503 (1ug/ml, Molecular Probes #D-3922). Alexa Fluor-514 (#A31558), 555 (#A21429), 594 (#A11032) and 647 (#A31571) (1:1000, Invitrogen) were used as secondary antibodies.
Western Blot Analysis
Cultured cells were lysed using the NE-PER nuclear and Cytoplasmic extraction kit (Pierce; Rockford, IL) for nuclear and cytoplasmic lysate. Protein concentrations were determined by BCA protein assay kit (Pierce) with BSA as standard. Gel electrophoresis was performed using precast Bis-Tris 4%-12% gradient polyacrylamide gels with NuPAGE buffer system (Invitrogen). Proteins were transferred to PVDF membranes (Immobilon-FL,Millipore) using the Xcell II Blot Module (Invitrogen). The membranes were blocked for 1 hr in Odyssey blocking buffer (Li-Cor biosciences, Cambridge, UK) and were probed with the following primary antibodies: PPARg, C/EBPa, C/EBPb and Insulin receptorb (1:500, Santa Cruz Biotechnology, Inc.), aP2/FAPB4 (1:3000, Cell Signaling Technology), adiponectin and perilipin (1:1000, Abcam). Detection was performed using a secondary antibody (1:3000) coupled to an IR 680 or IR 800 dye, and the membranes scanned using the Li-Cor Odyssey IR imager.
Model Description
The fixed parameters used were: degCEBPB = 0.1 ( 
The addition of GR and cAMP has been shown to directly cause upregulation of C/EBPb expression. The PPARg term reflects the fact that C/EBPb is in a positive feedback loop with PPARg. In addition to the experimental results we present in this paper, the existence of a feedback loop between PPARg to C/EBPb is supported by the fact that C/EBPb has been shown to bind directly to the PPARg promoter (Schmidt et al., 2011) and PPARg to the C/EBPb promoter (Mikkelsen et al., 2010) . However, despite the acquisition of several chromatin immunoprecipitation sequencing data sets (Siersbaek et al., 2011; Steger et al., 2010; Schmidt et al., 2011) , there is no evidence that C/EBPb binds to the C/EBPa promoter and vice versa. Thus, it is more likely that C/EBPb is in direct feedback loop with PPARg but not with C/EBPa. Thus Hill coefficients of at least 2 were chosen for the feedback loops in the first 3 equations. Given that the precise cooperativity is not known and is difficult to measure experimentally, we chose the respective Hill coefficients because lower cooperativity did not give sufficient bistability to match the experimental data. In the model, we used the minimal cooperativity needed to recapitulate the experimental data. (4) The amount of fat is dependent on both AKT activity (pAKT) and PPARg expression. However, the constants alpha7 and alpha8 were shown to reflect that the amount of fat is much more strongly dependent on pAKT than on PPARg expression. (7) Both PPARg and C/EBPa bind to their own promoters respectively (Lefterova et al., 2008; Steger et al., 2010) which suggests that these transcription factors could be regulated by autofeedback loops. We did not include autofeedback for PPARg or C/EBPa because there is no experimental evidence yet in the literature that they are regulated by autofeedback. Even though binding sites are present, one cannot assume actual transcriptional regulation without testing for this. An additional reason why we did not include autofeedback for PPARg is that our experimental results ( Figure 3E ) showed that knockdown of C/EBPa and subsequent activation of PPARg resulted in an almost complete reduction of PPARg expression, indicating at best only a minor role of an autofeedback PPARg loop if it does prove to exist. We did not include any autofeedback term in the C/EBPb equation in the model since no evidence has been shown yet even in large-scale CHIP studies that C/EBPb binds to its own promoter (Siersbaek et al., 2011; Steger et al., 2010) . (8) Small random variations were introduced to model parameters assuming log normal distribution of the parameters. (9) All models presented in this manuscript will be uploaded to the EMBL-EBI BioModels repository: (http://www.ebi.ac.uk/ biomodels-main/). Each histogram represents PPARg, C/EBPa and C/EBPb nuclear intensities from approximately 30,000 cells. At time 0, undifferentiated OP9 cells were stimulated with rosiglitazone (10 mM), red curves) for different pulse time periods or left in basal media (black curves), then washed three times with fresh medium, and then placed in fresh medium without rosiglitazone. Cells were fixed, stained with the respective antibodies, and analyzed using epifluorescence imaging.
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